C12N 2710/16361
Methods of inactivation or attenuation
C12N2710/16361 (Methods of inactivation or attenuation) appears on 20 US grants and 17 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 17
- Assignees
- 12
- Inventors
- 29
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 3 |
| 2019 | 3 | 6 |
| 2020 | 6 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof12 Aug 2025US 12,385,068 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof23 Aug 2022US 11,421,249 B2Boehringer Ingelheim Animal Health USA Inc.
- Duck Enteritis Virus and the uses thereof3 Nov 2020US 10,821,170 B2Ceva Sante Animale
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof3 Nov 2020US 10,822,620 B2Boehringer Ingelheim Animal Health USA Inc.
- Duck enteritis virus and the uses thereof21 Jul 2020US 10,717,967 B2Ceva Sante Animale
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof8 Jun 2023US 2023/0175017 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof14 Jan 2021US 2021/0010033 A1Boehringer Ingelheim Animal Health USA Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof15 Aug 2019US 2019/0249196 A1Boehringer Ingelheim Animal Health USA Inc.
- Duck enteritis virus and the uses thereof23 May 2019US 2019/0151439 A1Ceva Sante Animale
Most cited
By later US patents
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000
- Recombinant chimeric virus and uses thereof22US 6,183,753 B2Schering-Plough Veterinary Corporation · 2001
- Recombinant avian herpesvirus useful in vaccine production13US 6,913,751 B2Schering-Plough Veterinary Corporation · 2005
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof6US 10,323,257 B2Boehringer Ingelheim Animal Health USA Inc. · 2019
- Duck enteritis virus and the uses thereof5US 10,202,582 B2Ceva Sante Animale · 2019